Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pegylated Interferon Plus Ribavirin in Untreated Chronic Hepatitis C in Egypt
NCT00158496Phase 3Completed
- Sponsor
- ANRS
- Start
- Aug 2002
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 3 trial of peginterferon alfa-2a, ribavirin in hepatitis C (HCV), sponsored by ANRS. Started Aug 2002; status: completed.
02
Drugs
peginterferon alfa-2aribavirin
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT00158496.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00158496.